Initial Experience With A Uniquely Designed Device (The Chinese Fabulous Stent) Designed To Treat TBADs: What Makes It Different And How Does It Work

Why The NICE AAA Guidelines Favoring Open Repair Over EVAR Are The Way They Are: Bias Has Played A Role As It Does In Many Things: Randomized Controlled Trials (RCTs) Can Be Misleading

Cancer Is Associated With AAAs: It’s A Chicken And Egg Paradox; Which Came First, The Aneurysm Or The Cancer: Is It Related To Diagnostic And Therapeutic Radiation

The Link Between Elevated Cancer Risk And EVARs: Evidence From Biological Studies And A Large Population Based Data Analysis

What Do The New ESVS Guidelines For Elective And Emergent AAA Treatment Add To Vascular Practice In 2024: Big Changes Are Coming

The SVS/ESVS/NICE/ACC/AHA Guidelines On AAA: Agreements, Conflicting Recommendations, And Omissions

Evolving Role For Physician Modified Endografts (PMEGs) For Complex AAA Repair: Why Are Poor Results Underreported And When Are They Justified

Hospitals Without Investigational Device Exemptions Have Worse Outcomes After PMEGs: These Are Often Unreported

PMEGs For Juxta-And Para-Renal Aneurysms Come Out Of The Shadows And Are Now Mainstream: When Should They NOT Be Done

DEBATE: Population Screening With Ultrasound For Early Detection Of AAA Is Recommended For Women Age >65 Years, With A History Of Smoking Or A Family History Of AAA, And For Women Age >75 Years, With A History Of Smoking If They Are Otherwise In Good Health

DEBATE: Population Screening With Ultrasound For Early Detection Of AAA Is NOT Recommended For Women Age >65 Years, Even If They Are Former Or Current Smokers Or Have Cardiovascular Disease

Panel Discussion